Cholinergic

Type: Keyphrase

Name: Cholinergic

First Reported Mar 16 2010 - Updated Mar 16 2010 - 1 Documents

[Research Article] Cholinergic Augmentation of Insulin Release Requires Ankyrin-B

The scaffolding protein ankyrin-B is needed for maximal insulin release and loss of function is a risk factor for diabetes. ... [Published Mar 16 2010 by Science Magazine]

Entities: Cholinergic, Insulin, Protein

First Reported Mar 16 2010 - Updated Mar 16 2010 - 1 Documents

Adverse effects of drugs on small intestine and colon

Zeino Z et al. The most important factor in the diagnosis of druginduced intestinal side effect is awareness. The mechanisms of damage are invariably complex, but may be due to topical effects, a known pharmacologic action of the drug on motility (for ... [Published Mar 16 2010 by MDLinx]

Entities: small intestine, Enteropathy, Cytotoxic Drug, Anticholinergic, Cholinergic

First Reported Mar 16 2010 - Updated Mar 16 2010 - 1 Documents

Rivastigmine Shows Promise for Patients With Parkinson's Disease Dementia: Presented at ADI

-- Patients with Parkinson's disease dementia (PDD) respond to 2 weeks of treatment with rivastigmine by demonstrating improved short-term memory and decreased theta activity, according to preliminary results presented here on March 11 at the 25th Conference ... [Published Mar 16 2010 by Doctors Guide]

Entities: Rivastigmine, Parkinson's Disease, Dementia

First Reported Mar 03 2010 - Updated Mar 03 2010 - 1 Documents

In Down's Syndrome DYRK1A Gene May Be One Of Most Influential Factors

Research undertaken in recent years on Down's syndrome has focused on the DYRK1A gene. The superexpression of this gene affects transmission in the neurones, according to Mr Garikoitz Azkona. In his PhD thesis, The molecular bases of neuropathology in ... [Published Mar 03 2010 by Medical News Today]

Entities: Neuron, Cholinergic, Memory

First Reported Mar 03 2010 - Updated Mar 03 2010 - 1 Documents

National institutes of Health

Rapid Reduction of Depression With New Drug

Researchers at the National Institutes of Health (NIH) say that a novel drug has been found to reduce symptoms of depression within three days of the first administration, though it generally takes three to four weeks for conventional antidepressant treatments ... [Published Mar 03 2010 by MedIndia]

Entities: Scopolamine, Receptor, National institutes of Health

First Reported Mar 01 2010 - Updated Mar 02 2010 - 2 Documents

Research focuses on DYRK1A gene in association with Down's syndrome

Entities: Neuron, Cholinergic, Memory

First Reported Mar 02 2010 - Updated Mar 02 2010 - 1 Documents

Depression: Developing Faster Drugs

(Ivanhoe Newswire) -- An anti-nausea medication may be the secret to developing faster acting treatments for depression.While current medications for depression usually take three to four weeks to work, researchers have found scopolamine -- currently ... [Published Mar 02 2010 by Medical Breakthroughs]

Entities: Receptor, Scopolamine, Cholinergic, Biological Psychiatry, Antidepressants

First Reported Mar 01 2010 - Updated Mar 01 2010 - 1 Documents

Systemic infection and delirium: when cytokines and acetylcholine collide

van Gool WA et al. Systemic infection and drugs with anticholinergic effects are wellrecognised and prevalent risk factors for delirium in elderly people. Experimental findings and neuropathological observations suggest that activation of microglia is ... [Published Mar 01 2010 by MDLinx]

Entities: Acetylcholine, cytokine, Cholinergic

First Reported Feb 26 2010 - Updated Feb 26 2010 - 1 Documents

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

Klein JC et al. Patients with dementia with Lewy bodies and Parkinson disease dementia share the same dopaminergic and cholinergic deficit profile in the brain and seem to represent 2 sides of the same coin in a continuum of Lewy body diseases. Cholinergic ... [Published Feb 26 2010 by MDLinx]

Entities: Dementia with Lewy bodies, Neurotransmitter, Cholinergic, In Vivo

First Reported Oct 22 2009 - Updated Oct 22 2009 - 1 Documents

Michael Markarian: Helping Vets, Pets, and Primates

Congress took two steps in recent days on animal issues, as part of its larger bills related to the Department of Defense and military spending. I wrote back in July about legislation introduced by Senators Al Franken (D-Minn.) and Johnny ... [Published Oct 22 2009 by The Huffington Post Full Blog Feed]

Entities: Al Franken, Ed Whitfield, Ron Klein

Quotes

"Scopolamine was found to reduce symptoms of depression within three days of the first administration. In fact, participants reported that they experienced relief from their symptoms by the morning after the first administration of drug" Dr. Furey said

Rapid Reduction of Depression With New Drug [MedIndia - Mar 03 2010]

...Maura Furey, of the National Institutes of Health, was quoted as saying. "Moreover, one-half of participants experienced full symptom remission by the end of the treatment period."

Depression: Developing Faster Drugs [Medical Breakthroughs - Mar 02 2010]

Dr JohnJohn Krystal, Editor of Biological Psychiatry, commented that these findings "have the potential to raise expectations for new antidepressant treatments. Three-to-six weeks is a long time to wait for depression symptoms to be alleviated. Depressed people describe their emotional state using terms like 'agony' and others compare their condition to 'living in hell'. Further, depression is a life-threatening condition for some, preventing them from performing basic self-care functions or causing them to exhibit self-destructive behavior."

Scopolamine drug: A rapid-acting antidepressant for depression symptoms [News-Medical.Net - Mar 02 2010]

More Content

sort by: Date \| Relevance
[Research Article] Cholinergic Augmentation of ... [Science Magazine - Mar 16 2010]
Adverse effects of drugs on small intestine and... [MDLinx - Mar 16 2010]
Rivastigmine Shows Promise for Patients With Pa... [Doctors Guide - Mar 16 2010]
Autism - Drug Pipeline Analysis and Market Fore... [Research and Markets - Mar 04 2010]
In Down's Syndrome DYRK1A Gene May Be One Of M... [Medical News Today - Mar 03 2010]
Rapid Reduction of Depression With New Drug [MedIndia - Mar 03 2010]
Research focuses on DYRK1A gene in association ... [News-Medical.Net - Mar 02 2010]
Depression: Developing Faster Drugs [Medical Breakthroughs - Mar 02 2010]
Scopolamine drug: A rapid-acting antidepressant... [News-Medical.Net - Mar 02 2010]
Scopolamine drug appears to reduce major depres... [News-Medical.Net - Mar 02 2010]
DYRK1A gene may be 1 of most influential factor... [EurekAlert! - Mar 01 2010]
Systemic infection and delirium: when cytokines... [MDLinx - Mar 01 2010]
Neurotransmitter changes in dementia with Lewy ... [MDLinx - Feb 26 2010]
SRI International establishes new Neurodegenera... [News-Medical.Net - Feb 19 2010]
Dementia: A Focused Review [Consultant Live - Feb 12 2010]
Jimsonweed Poisoning Associated with a Homemade... [Food Consumer - Feb 11 2010]
The Golden Age of Dry Eye Management [Review of Optometry - Feb 10 2010]
Dementia: A Focused Review [Psychiatric Times - Feb 10 2010]
Garry Kasparov On 'Chess Metaphors': The Chess ... [The Huffington Post \| Full News Feed - Jan 22 2010]
Dainippon Sumitomo seeks US FDA approval for lu... [PharmaBiz - Jan 06 2010]
Ipsen launches Dysport in US to treat cervical ... [PharmaBiz - Nov 02 2009]
Dr Reddy's launches Bispec in India [PharmaBiz - Jun 23 2009]

Advanced Search Options

Cholinergic